# A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life

> **NCT03378388** · — · TERMINATED · sponsor: **Takeda** · enrollment: 29 (actual)

## Conditions studied

- Colitis, Ulcerative
- Crohn Disease
- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03378388
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-13
- **Primary completion:** 2019-02-15
- **Final completion:** 2019-02-15
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Business Decision; Insufficient Enrollment
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378388, "A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03378388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*